Government of Saskatchewan ministries, Crown corporations and organizations are implementing contingency plans to minimize the impacts of postal service disruption.
Les ministères, sociétés d’État et organismes du gouvernement de la Saskatchewan mettent en œuvre des plans d’urgence visant à réduire les répercussions de l’interruption du service des postes.
Google Translate Disclaimer
A number of pages on the Government of Saskatchewan's website have been professionally translated in French. These translations are identified by a yellow box in the right or left rail that resembles the link below. The home page for French-language content on this site can be found at:
Where an official translation is not available, Google™ Translate can be used. Google™ Translate is a free online language translation service that can translate text and web pages into different languages. Translations are made available to increase access to Government of Saskatchewan content for populations whose first language is not English.
Software-based translations do not approach the fluency of a native speaker or possess the skill of a professional translator. The translation should not be considered exact, and may include incorrect or offensive language. The Government of Saskatchewan does not warrant the accuracy, reliability or timeliness of any information translated by this system. Some files or items cannot be translated, including graphs, photos and other file formats such as portable document formats (PDFs).
Any person or entities that rely on information obtained from the system does so at his or her own risk. Government of Saskatchewan is not responsible for any damage or issues that may possibly result from using translated website content. If you have any questions about Google™ Translate, please visit: Google™ Translate FAQs.
Antiviral medications may be used in the early treatment of mild to moderate COVID-19 illness in patients who are at high risk for progression to severe illness that may require hospitalization.
Antiviral treatments, Paxlovid™ and remdesivir (Veklury™), help reduce the viral load of COVID-19 virus in the body. They are not used to prevent COVID-19 infection before you test positive. Treatments are only effective when initiated in the very early phase of infection.
While most vaccinated people have enough immunity to fight COVID-19 infection, those who are moderately to severely immunocompromised may benefit from antiviral therapy.
Treatment for COVID-19 is Not a Substitute for Vaccination.
Treatment for COVID-19 does not offer equal protection to vaccination. Getting vaccinated remains the most important intervention to reduce the risk of hospitalization and other severe outcomes from COVID-19.
Treatment with Paxlovid™ must start within five days of symptom onset. The medication consists of tablets taken every 12 hours for five days.
A physician or nurse practitioner will decide whether to prescribe an antiviral medication, taking into consideration patient risks, current medications, and underlying conditions.
Coverage for Paxlovid™ may be available based on eligibility. Eligibility criteria can be found at the medSask website under Paxlovid Prescribing and Eligibility Criteria.
Additional information, including the Paxlovid™ Prescription form for healthcare professionals on COVID-19 therapeutics (i.e., Paxlovid ™) can be found at the medSask website.
Treatment with remdesivir must start within seven days of symptom onset. This is an intravenous treatment of at least 60 minutes daily for three consecutive days.
A physician or nurse practitioner will decide whether to prescribe remdesivir (Veklury™), taking into consideration patient risks, current medications, and underlying conditions.
We need your feedback to improve saskatchewan.ca. Help us improve
